Back to today’s briefing

Story perspectives

Eight Chinese Firms Secure Hong Kong Listings Amid Surge

4/22/2026

50 8 Full Breakdown

Summary

Story summary

In April 2026, eight Chinese companies, including five biotech firms, passed Hong Kong listing hearings.
The hearings follow a CSRC push for private firms to list in Hong Kong.
Metis TechBio, founded 2020, applied under a special listing regime for pre-profit tech firms and posted 105 million yuan revenue last year after completing phase three trials.
Average daily turnover on the Hong Kong Stock Exchange rose 14% in early 2026.

1 of 1

Story summary

In April 2026, eight Chinese companies, including five biotech firms, passed Hong Kong listing hearings.
The hearings follow a CSRC push for private firms to list in Hong Kong.
Metis TechBio, founded 2020, applied under a special listing regime for pre-profit tech firms and posted 105 million yuan revenue last year after completing phase three trials.
Average daily turnover on the Hong Kong Stock Exchange rose 14% in early 2026.